The Athlete Biological Passport: an integral element of innovative strategies in antidoping
- PMID: 24659508
- DOI: 10.1136/bjsports-2014-093560
The Athlete Biological Passport: an integral element of innovative strategies in antidoping
Abstract
Concern for the health of athletes and integrity of sport resulted in the banning of specific substances although many years passed before analytical testing took place. Soon doping control programmes became synonymous with urine tests and adverse analytical findings. This system has its limits due to the detection window of prohibited substances, the timing of sample collections and the sophistication of some doping regimens. There have been a number of situations where these limits were demonstrated by athletes who proclaimed innocence based on passing their analytical tests only to later confess to doping. New strategies were called for to protect clean athletes. In the current World Anti-Doping Code, there are eight means to an Anti-Doping Rule Violation (ADRV). Article 2.2 states that the use of a prohibited substance may be established by any reliable means including witness statements, documentary evidence or evaluations of longitudinal profiling. In 2006, the World Anti-Doping Agency (WADA) with the support of some International Federations (IFs) gathered a group of experts to develop a harmonised programme on longitudinal profiling, or serial analysis of indirect biomarkers of doping, that was both scientifically and legally robust. This culminated in the WADA Athlete Biological Passport (ABP) Operating Guidelines and Technical Documents, published in 2009. The ABP is a paradigm that infers the use of prohibited substance (or method) by the monitoring of discriminant biomarkers over time. The haematological module detects blood manipulation by the use of erythropoietic stimulating agents or via blood transfusions. The steroidal module aims to identify endogenous anabolic androgenic steroids when administered exogenously and other indirect steroid doping substances or methods. Other ABP modules (endocrine, 'omics') are being developed. The term passport, first coined in 2000, is now defined in the ABP Guidelines as the longitudinal profile and all other relevant information including training, competitions and information derived from investigations. In the 2015 World Anti-Doping Code, investigations or enquiries gathered from other sources will play an even more prominent role.
Keywords: Doping; Drug control; Drug use; Ethics.
Similar articles
-
Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.Br J Sports Med. 2014 May;48(10):862-6. doi: 10.1136/bjsports-2014-093567. Epub 2014 Mar 19. Br J Sports Med. 2014. PMID: 24648438
-
Monitoring of biological markers indicative of doping: the athlete biological passport.Br J Sports Med. 2014 May;48(10):827-32. doi: 10.1136/bjsports-2014-093512. Epub 2014 Mar 21. Br J Sports Med. 2014. PMID: 24659506 Review.
-
A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.Br J Sports Med. 2014 May;48(10):810-3. doi: 10.1136/bjsports-2014-093531. Epub 2014 Mar 18. Br J Sports Med. 2014. PMID: 24642697
-
Biomarker monitoring in sports doping control.Bioanalysis. 2012 Jun;4(10):1245-53. doi: 10.4155/bio.12.101. Bioanalysis. 2012. PMID: 22651568 Review.
-
Challenges and perspectives in anti-doping testing.Bioanalysis. 2012 Jul;4(13):1691-701. doi: 10.4155/bio.12.145. Bioanalysis. 2012. PMID: 22831484
Cited by
-
Antidoping programme and biological monitoring before and during the 2014 FIFA World Cup Brazil.Br J Sports Med. 2015 May;49(9):614-22. doi: 10.1136/bjsports-2015-094762. Br J Sports Med. 2015. PMID: 25878079 Free PMC article.
-
The Critical Power Model as a Potential Tool for Anti-doping.Front Physiol. 2018 Jun 6;9:643. doi: 10.3389/fphys.2018.00643. eCollection 2018. Front Physiol. 2018. PMID: 29928234 Free PMC article. Review.
-
Performance assessment of an equine metabolomics model for screening a range of anabolic agents.Metabolomics. 2023 Apr 7;19(4):38. doi: 10.1007/s11306-023-01985-0. Metabolomics. 2023. PMID: 37027080
-
Metabolomics in clinical and forensic toxicology, sports anti-doping and veterinary residues.Drug Test Anal. 2022 May;14(5):794-807. doi: 10.1002/dta.3245. Epub 2022 Mar 8. Drug Test Anal. 2022. PMID: 35194967 Free PMC article. Review.
-
Biological variation: Understanding why it is so important?Pract Lab Med. 2021 Jan 4;23:e00199. doi: 10.1016/j.plabm.2020.e00199. eCollection 2021 Jan. Pract Lab Med. 2021. PMID: 33490349 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical